Crohn's Disease and Colitis Trial, Recruiting NCT06655415 Sponsor: Massachusetts General Hospital Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06655415
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able to give informed consent to participate in the study
  • People who are able to attend all required study visits and complete all study-related tasks
  • People who are able to understand and fill out study questionnaires
  • People who have at least one close blood relative (such as a parent, sibling, or child) who has been diagnosed with inflammatory bowel disease (IBD), which includes Crohn's disease, ulcerative colitis, or a similar condition
  • People who are 14 years of age or older

Who may not be able to join:

  • People who have already been diagnosed with inflammatory bowel disease (such as ulcerative colitis, Crohn's disease, or a similar condition)
  • People who are already showing signs or symptoms that may suggest inflammatory bowel disease, as determined during an initial screening interview with the study team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emily W Lopes, MD, MPH, Massachusetts General Hospital

Phone: 617-726-5560

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 December 2024
Est. completion
1 December 2034

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants who develop inflammatory bowel disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov